AbbVie

AbbVie is a global biopharmaceutical company based in the United States, known for its focus on research and development in immunology, oncology, and virology. Formed in 2013 as a spin-off from Abbott Laboratories, AbbVie has gained recognition for its innovative treatments, particularly in the field of autoimmune diseases and cancer therapies. The company has been actively involved in expanding its portfolio through strategic acquisitions and collaborations, contributing significantly to advancements in the pharmaceutical industry.